Loading...
XSTO
BRAIN
Market cap25mUSD
Jul 11, Last price  
1.53SEK
1D
-1.29%
1Q
-8.93%
Jan 2017
-81.59%
IPO
-48.48%
Name

BrainCool AB (publ)

Chart & Performance

D1W1MN
P/E
P/S
6.14
EPS
Div Yield, %
Shrs. gr., 5y
29.57%
Rev. gr., 5y
56.50%
Revenues
40m
+72.05%
779,733998,7871,287,2434,256,0517,032,0619,264,34217,588,40723,227,00439,961,000
Net income
-44m
L-28.13%
-13,482,278-23,081,547-38,939,469-57,282,019-37,304,149-38,750,101-45,612,929-61,275,951-44,042,000
CFO
-63m
L+2.41%
-15,185,017-29,142,023-25,280,277-56,011,266-39,249,729-24,247,129-46,268,680-61,160,433-62,636,000

Profile

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers products for medical cooling treatments for a range of diseases, including stroke, sudden cardiac arrest, oral mucositis, and migraine. It provides BrainCool and RhinoChill systems that facilitates rapid medical cooling treatment in an emergency setting and ensures the continuum of care; Cooral system provides medical professionals an easy way to reduce the risk of oral mucositis; and IQool system offers an easy-to-use intuitive interface, informative graphics, and an automatic feedback loop allowing clinicians to manage their patient rather than a device. The company was incorporated in 2010 and is based in Lund, Sweden.
IPO date
May 07, 2014
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
39,961
72.05%
23,227
32.06%
17,588
89.85%
Cost of revenue
26,829
11,111
66,007
Unusual Expense (Income)
NOPBT
13,132
12,116
(48,419)
NOPBT Margin
32.86%
52.16%
Operating Taxes
228
105
29
Tax Rate
1.74%
0.87%
NOPAT
12,904
12,011
(48,447)
Net income
(44,042)
-28.13%
(61,276)
34.34%
(45,613)
17.71%
Dividends
Dividend yield
Proceeds from repurchase of equity
76,799
56,900
116,279
BB yield
-25.58%
-5.67%
-80.29%
Debt
Debt current
9
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(31,402)
(25,063)
(41,665)
Cash flow
Cash from operating activities
(62,636)
(61,160)
(46,269)
CAPEX
(7,568)
(1,342)
(7,400)
Cash from investing activities
(7,568)
(6,167)
(7,587)
Cash from financing activities
76,799
50,931
81,279
FCF
(10,852)
5,958
(49,522)
Balance
Cash
31,402
25,063
41,206
Long term investments
468
Excess cash
29,404
23,901
40,794
Stockholders' equity
11,403
(319,494)
(265,017)
Invested Capital
134,528
431,230
381,249
ROIC
4.56%
2.96%
ROCE
9.00%
10.84%
EV
Common stock shares outstanding
219,160
209,908
89,948
Price
1.37
-71.34%
4.78
196.89%
1.61
-78.53%
Market cap
300,249
-70.08%
1,003,358
592.85%
144,816
-79.65%
EV
268,847
978,295
362,989
EBITDA
15,911
12,116
(45,925)
EV/EBITDA
16.90
80.75
Interest
7,288
618
8,045
Interest/NOPBT
55.50%
5.10%